Categories: News

Expanding Innovations Announces Attendance & Participation at upcoming Investor Conferences

MOUNTAIN VIEW, Calif., March 6, 2025 /PRNewswire/ — Expanding Innovations (EI), an emerging leader in expandable implant technology for spine surgery, announced today that it will be attending and participating in the Canaccord Genuity Musculoskeletal and LSI USA Investor Conferences in March, 2025.

  • March 10, 2025 – Expanding Innovations has been invited to present at the Canaccord Genuity Musculoskeletal Conference in San Diego, California. EI will be delivering a company presentation in the Plaza Room at 1:00pm PT on Monday, March 10th and will host one-on-one meetings throughout the day on both the 10th and the 11th. Investors may contact their Canaccord representative for additional information.
  • March 17-21, 2025 – Expanding Innovations will attend the LSI USA Conference in Dana Point, California. Board Members and Executive Management will be hosting one-on-one meetings with investors throughout the Conference. Investors may contact IR@expandinginnovations.com for additional information.

Connect with Expanding Innovations to learn more about:

  • How X-PAC® Expandable Interbody Technology raises the bar in one of the Spine Industry’s fastest-growing product segments.
  • EI’s X-PAC® non-screw based expandable cages – designed to mitigate the incidence of post-op cage collapse and vertebral body subsidence.
  • EI’s recent milestones and aggressive commercial growth strategy.
  • The continued innovation and expansion of EI’s flagship X-PAC® product portfolio.

About Expanding Innovations

Expanding Innovations is an emergiwng medical device leader in expandable implant technology for spine surgery. Committed to solving the most formidable clinical problems faced by today’s spine surgeons, EI recognized the need to develop a next-generation expandable interbody cage platform that would mitigate the incidence of post-op cage collapse and vertebral body subsidence. Rising to the challenge, EI developed a revolutionary, NON-SCREW-based expandable cage that surgeons and patients can count on.  X-PAC® Expandable Interbody Cages replace the traditional inner implant drive screw with a powerful, continuous lifting mechanism. This patented lifting mechanism provides exceptional tactile feedback to the surgeon throughout implant expansion and robust locking of the implant upon completion of expansion. With over 14,000 cages implanted, surgeon adoption and trust in X-PAC Expandable Interbody Cage technology continues to grow across the United States.  Expanding Innovations continues to innovate with significant technology advancements and planned expansion of its X-PAC Portfolio in 2026.

For more information about Expanding Innovations and our participation in these events, please visit ExpandingInnovations.com or follow us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/expanding-innovations-announces-attendance–participation-at-upcoming-investor-conferences-302394024.html

SOURCE Expanding Innovations

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

8 minutes ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

8 minutes ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

8 minutes ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

8 minutes ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

8 minutes ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

8 minutes ago